FindTrial
Sign In

A randomized controlled trial of classic cut-and-sew Cox maze III procedure for atrial fibrillation associated with rheumatic mitral valve disease in a single-center

A randomized controlled trial of classic cut-and-sew Cox maze III procedure for atrial fibrillation associated with rheumatic mitral valve disease in a single-center

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007269
Enrollment
Unknown
Registered
2015-10-22
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Maze III group:cut-and-sew Cox maze III procedure plus mitral valve replacement
non-maze III group:only mitral valve replacemnet

Sponsors

General Hospital of Shenyang Millitary Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with persistent or long-standing persistent atrial fibrillation associated with rheumatic mitral valve disease were included.

Exclusion criteria

Exclusion criteria: Patients who suffered from degenerative or ischemic mitral valve lesion and patients with paroxysma atrial fibrillation were excluded. In addition, patients who underwent MVR and aortic valve replacement were also excluded.

Design outcomes

Primary

MeasureTime frame
survival rate at 1 year;Freedom from stroke at 1 year;—

Secondary

MeasureTime frame
Freedom from atrial fibrillation;—

Countries

China

Contacts

Public ContactWang Huishan

General Hospital of Shenyang Military Region Command

huishanwang@hotmail.com+86 024 28897381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026